Overview

Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the toxicity and efficacy of docetaxel and cisplatin combination on two schedules in patients with previously untreated, advanced NSCLC.
Phase:
Phase 2
Details
Lead Sponsor:
Gachon University Gil Medical Center
Treatments:
Cisplatin
Docetaxel